Set Targets Not Price Limits, German Industry Pleads

Plans for reference-price group for four anti-TNFs, including adalimumab and etanercept

Antibody
Therapeutic comparability between four TNF-alpha inhibitors has led German authorities to propose putting them in the same reference-pricing group • Source: Shutterstock

More from Biosimilars

More from Products